Trastuzumab BS for intravenous infusion 150 mg “Pfizer” is a biosimilar of trastuzumab (genetical recombination), manufactured by Pfizer. This injectable drug (YJ code: 4291447D2024) is supplied as 150mg per bottle, indicated for the treatment of HER2-positive breast cancer and metastatic gastric cancer.
Trastuzumab BS for intravenous infusion 150 mg “Pfizer”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →